Physiol. Genomics Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics 31: 193-202, 2007. First published June 12, 2007; doi:10.1152/physiolgenomics.00079.2007
1094-8341/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
31/2/193    most recent
00079.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vellaichamy, E.
Right arrow Articles by Pandey, K. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vellaichamy, E.
Right arrow Articles by Pandey, K. N.
Received 7 April 2007; accepted in final form 8 June 2007.
Physiological Genomics 31:193-202 (2007)
1094-8341/07 $8.00 © 2007 American Physiological Society

Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy

Elangovan Vellaichamy, Di Zhao, Naveen Somanna and Kailash N. Pandey

Department of Physiology, Tulane University School of Medicine, New Orleans, Louisiana

Guanylyl cyclase/natriuretic peptide receptor-A (GC-A/NPRA) signaling antagonizes the physiological effects mediated by the renin-angiotensin system (RAS). The objective of this study was to determine whether the targeted-disruption of Npr1 gene (coding for GC-A/NPRA) leads to the activation of cardiac RAS genes involved on the hypertrophic remodeling process. The Npr1 gene-knockout (Npr1–/–) mice showed 30–35 mmHg higher systolic blood pressure (SBP) and a 63% greater heart weight-to-body weight (HW/BW) ratio compared with wild-type (Npr1+/+) mice. The mRNA levels of both angiotensin-converting enzyme and angiotensin II type 1a receptor were increased by three- and fourfold, respectively, in Npr1–/– null mutant mice hearts compared with the wild-type Npr1+/+ mice hearts. In parallel, the expression levels of interleukin-6 and tumor necrosis factor-{alpha} were increased by four- to fivefold, in Npr1–/– mice hearts compared with control animals. The NF-{kappa}B binding activity in nuclear extracts of Npr1–/– mice hearts was increased by fourfold compared with wild-type Npr1+/+ mice hearts. Treatments with captopril or hydralazine equally attenuated SBP; however, only captopril significantly decreased the HW/BW ratio and suppressed cytokine gene expression in Npr1–/– mice hearts. The ventricular cGMP level was reduced by almost sixfold in Npr1–/– mice compared with wild-type control mice. The results of the present study indicate that disruption of NPRA/cGMP signaling leads to the augmented expression of cardiac RAS pathways that promote the development of cardiac hypertrophy and remodeling.

angiotensin-converting enzyme; angiotensin II type 1 receptor; hypertension; cardiac hypertrophy; angiotensin II; cytokines




This article has been cited by other articles:


Home page
Circ. Res.Home page
P. Li, D. Wang, J. Lucas, S. Oparil, D. Xing, X. Cao, L. Novak, M. B. Renfrow, and Y.-F. Chen
Atrial Natriuretic Peptide Inhibits Transforming Growth Factor {beta}-Induced Smad Signaling and Myofibroblast Transformation in Mouse Cardiac Fibroblasts
Circ. Res., February 1, 2008; 102(2): 185 - 192.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.